Piano stool Ru (II)-arene complexes having three monodentate legs: A comprehensive review on their development as anticancer therapeutics over the past decade

S Swaminathan, J Haribabu, N Balakrishnan… - Coordination chemistry …, 2022 - Elsevier
The popularity of RAPTA-C in in vivo studies has steered the way for complexes of the type
[Ru (η 6-arene)(X)(Y)(Z)] n+ (where X, Y and Z are monodentate ligands) to be developed …

Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands

WDJ Tremlett, DM Goodman, TR Steel, S Kumar… - Coordination chemistry …, 2021 - Elsevier
The small molecule anticancer agent cisplatin and its Pt (II) analogs carboplatin and
oxaliplatin are widely used to treat a variety of tumorigenic diseases. Despite their structural …

Synthesis and Structure of Arene Ru(II) NO-Chelating Complexes: In Vitro Cytotoxicity and Cancer Cell Death Mechanism

S Balaji, MK Mohamed Subarkhan, R Ramesh… - …, 2020 - ACS Publications
A panel of six new structurally related organometallic arene Ru (II) complexes of general
composition [(η6-benzene) Ru (L) Cl](1–3) and [(η6-p-cymene) Ru (L) Cl](4–6)(L …

Novel tetranuclear ruthenium (II) arene complexes showing potent cytotoxic and antimetastatic activity as well as low toxicity in vivo

MKM Subarkhan, L Ren, B Xie, C Chen, Y Wang… - European journal of …, 2019 - Elsevier
Ruthenium complexes have attracted a surge of interest as anticancer drug candidates
because of their low toxicity, diversity in mode-of-actions and non-cross drug resistance with …

Synthesis and structure of new binuclear ruthenium (II) arene benzil bis (benzoylhydrazone) complexes: investigation on antiproliferative activity and apoptosis …

MSM Kasim, S Sundar, R Rengan - Inorganic chemistry frontiers, 2018 - pubs.rsc.org
A series of binuclear ruthenium (II) arene benzil bis (benzoylhydrazone) complexes (1–6) of
the common composition [(η6-arene) 2Ru2 (L) Cl2](arene= benzene or p-cymene; L= benzil …

Construction of homo and heteronuclear Ru (II), Ir (III) and Re (I) complexes for target specific cancer therapy

S Pete, N Roy, B Kar, P Paira - Coordination Chemistry Reviews, 2022 - Elsevier
More than 10 million death tolls in 2020 were reported as a result of heinous impact of
cancer, making it second most prime cause of death after cardiovascular diseases. In …

Antiproliferative activity of chelating N, O-and N, N-ruthenium (II) arene functionalised poly (propyleneimine) dendrimer scaffolds

P Govender, AK Renfrew, CM Clavel, PJ Dyson… - Dalton …, 2011 - pubs.rsc.org
Chelating neutral (N, O) and cationic (N, N) first-and second-generation ruthenium (II) arene
metallodendrimers based on poly (propyleneimine) dendrimer scaffolds were obtained from …

Recent advances in cytotoxicity, cellular uptake and mechanism of action of ruthenium metallodrugs: A review

P Sudhindra, SA Sharma, N Roy, P Moharana, P Paira - Polyhedron, 2020 - Elsevier
Due to these limitations of platinum-based drugs, it has now become a challenge for
researchers to find out a potential scaffold furnished with indispensable properties like …

Tuning the cytotoxicity of ruthenium (II) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand

L Biancalana, S Zacchini, N Ferri, MG Lupo… - Dalton …, 2017 - pubs.rsc.org
The new complexes [RuCl2 (η6-p-cymene)(κP-Ph2PR)][R= 4-C6H4OSiMe2tBu, 1; R= 4-
C6H4Br, 2; R= OC (O) CHCl2, 3; R= OPh, 4; R= O (2-C6H4SiMe2tBu), 5] and [Ru (C2O4)(η6 …

Synthesis and antiproliferative activity of new ruthenium complexes with ethacrynic-acid-modified pyridine and triphenylphosphine ligands

G Agonigi, T Riedel, S Zacchini, E Paunescu… - Inorganic …, 2015 - ACS Publications
Pyridine-and phosphine-based ligands modified with ethacrynic acid (a broad acting
glutathione transferase inhibitor) were prepared and coordinated to ruthenium (II)–arene …